---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-007340"
form_type: "8-K"
ticker: "AVR"
cik: "0002011514"
company_name: "Anteris Technologies Global Corp."
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T07:49:48.848065+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anteris Technologies appoints David St Denis as President and Class II director

## Summary
- Appointment effective March 5, 2025; St Denis retains COO role and serves as CEO of v2vmedtech.
- St Denis has been COO since July 2017; prior roles include Merck and Millennium Pharmaceuticals.
- No material amendment to compensatory arrangements; no new grants or awards in connection.
- St Denis will not sit on any Board committees due to non-independent status.

## SEC filing metadata
- accession: 0001140361-25-007340
- form_type: 8-K
- ticker: AVR
- cik: 0002011514
- company_name: Anteris Technologies Global Corp.
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/ef20045020_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-007340
- JSON: https://secwatch.observer/filing/0001140361-25-007340.json
- Plain text: https://secwatch.observer/filing/0001140361-25-007340.txt

## Key facts
- Executive change
  David St Denis was appointed as Class II director at Anteris Technologies Global Corp..
  - Action: appointed
  - Role: Class II director
  source text: On March 5, 2025 (March 6, 2025 in Australia), the Board of Directors (the “Board”) of Anteris Technologies Global Corp. (the “Company”) appointed David St Denis as the Company’s President and as a Class II director of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm
- Executive change
  David St Denis was appointed as President at Anteris Technologies Global Corp..
  - Action: appointed
  - Role: President
  source text: On March 5, 2025 (March 6, 2025 in Australia), the Board of Directors (the “Board”) of Anteris Technologies Global Corp. (the “Company”) appointed David St Denis as the Company’s President and as a Class II director of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2011514/000114036125007340/0001140361-25-007340-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.